Author + information
- Sagar Mallikethi-Reddya,b,
- Naveen Trehana,b,
- Shanker Kundumadama,b,
- Aditya Sooda,b,
- Rajeev Sudhakara,b,
- Melvyn Rubenfirea,b,
- Mazhar Khana,b,
- Luis Afonsoa,b and
- Cindy Grinesa,b
Background: Predictors of early home discharge (≤3 days) after transcatheter aortic valve implantation (TAVI) have been poorly studied in the United States.
Methods: We analyzed data from the Healthcare Utilization Project, Nationwide inpatient Sample database, 2011-2012. A total of 7,321 TAVI procedures were identified using ICD-9CM procedure codes- 35.05; 35.06. We determined the overall post-TAVI length of stay, costs of hospitalization and predictors of early home discharge.
Results: Early home discharge rate post-TAVI was about 18% in the United States, in 2011-2012. Overall mean age was 81 years. Mean length of stay post-TAVI (2.6 days vs. 6.6 days) and mean hospitalization costs ($149,234 vs. $197,895) were significantly lower in early home discharge cohort than overall cohort. On multivariate analysis (Table), females, bleeding, blood transfusions, permanent pacemakers, mechanical circulatory support device use, acute kidney injury were associated with significantly lower adjusted odds for early home discharge. Transfemoral TAVI approach and procedure year 2012 were associated with significantly higher odds for early home discharge.
Conclusions: Females, bleeding, blood transfusions, permanent pacemakers, mechanical circulatory support devices, acute kidney injury were associated with lower odds for early home discharge. Transfemoral approach increased the likelihood for early home discharge when compared to transapical approach.
Poster Hall, Hall C
Saturday, March 18, 2017, 3:45 p.m.-4:30 p.m.
Session Title: Interventional Cardiology: PCI and TAVR in Complex Patients
Abstract Category: 24. Interventional Cardiology: Mitral and Structural Heart Disease
Presentation Number: 1239-126
- 2017 American College of Cardiology Foundation